Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Zastaprazan [inn]
2. W9s9kzx5md
3. Unii-w9s9kzx5md
4. 2133852-18-1
5. 1-azetidinyl(8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)methanone
6. Methanone, 1-azetidinyl(8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)-
7. Schembl20986992
8. Akos040757321
9. Ms-25766
10. Hy-139557
11. Cs-0204155
Molecular Weight | 362.5 g/mol |
---|---|
Molecular Formula | C22H26N4O |
XLogP3 | 4.4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 49.6 |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 526 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
72
PharmaCompass offers a list of Zastaprazan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zastaprazan manufacturer or Zastaprazan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zastaprazan manufacturer or Zastaprazan supplier.
PharmaCompass also assists you with knowing the Zastaprazan API Price utilized in the formulation of products. Zastaprazan API Price is not always fixed or binding as the Zastaprazan Price is obtained through a variety of data sources. The Zastaprazan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zastaprazan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zastaprazan, including repackagers and relabelers. The FDA regulates Zastaprazan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zastaprazan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zastaprazan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zastaprazan supplier is an individual or a company that provides Zastaprazan active pharmaceutical ingredient (API) or Zastaprazan finished formulations upon request. The Zastaprazan suppliers may include Zastaprazan API manufacturers, exporters, distributors and traders.
click here to find a list of Zastaprazan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zastaprazan Drug Master File in Korea (Zastaprazan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zastaprazan. The MFDS reviews the Zastaprazan KDMF as part of the drug registration process and uses the information provided in the Zastaprazan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zastaprazan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zastaprazan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zastaprazan suppliers with KDMF on PharmaCompass.
Zastaprazan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zastaprazan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zastaprazan GMP manufacturer or Zastaprazan GMP API supplier for your needs.
A Zastaprazan CoA (Certificate of Analysis) is a formal document that attests to Zastaprazan's compliance with Zastaprazan specifications and serves as a tool for batch-level quality control.
Zastaprazan CoA mostly includes findings from lab analyses of a specific batch. For each Zastaprazan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zastaprazan may be tested according to a variety of international standards, such as European Pharmacopoeia (Zastaprazan EP), Zastaprazan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zastaprazan USP).